Literature DB >> 12841680

Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients.

M Hebbar1, M A Krzewinski-Recchi, L Hornez, A Verdière, A Harduin-Lepers, J Bonneterre, P Delannoy, J P Peyrat.   

Abstract

AIMS AND
BACKGROUND: A crucial step in the metastatic process is the interaction between the endothelial molecule E-selectin and its tumoral ligands sialyl-Lewis- and sialyl-Lewis. Sialyltranferases are involved in the biosynthesis of these ligands. The aim of this study was to assess the prognostic value of tumoral sialyltransferase expression and of circulating soluble E-selectin (sE-selectin) in node-negative breast cancer patients.
METHODS: Using a multiplex RT-PCR method, we measured the expression of five sialyltransferases (ST3Gal III, ST6Gal I, ST3Gal IV, ST3Gal I and ST3Gal II) in tumors of 135 surgically treated node-negative breast cancer patients. Circulating sE-selectin concentrations were measured by an ELISA method prior to surgery. We also analyzed tumor size, histoprognostic grading and steroid hormone receptor status.
RESULTS: The median follow-up was 7.5 years. Expression of estrogen receptors was associated with a good prognosis for relapse-free survival in univariate analysis. A high ST3Gal III/ST6Gal I ratio and a high sE-selectin concentration were associated with a bad prognosis for relapse-free survival and overall survival in univariate and multivariate analysis.
CONCLUSION: In the present study, tumoral sialyltransferase expression and circulating sE-selectin concentrations had prognostic value in patients with node-negative breast cancer. This result provides further evidence for the important role of these agents in the metastatic process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841680     DOI: 10.1177/172460080301800204

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


  13 in total

1.  Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells.

Authors:  Rosa Peracaula; Glòria Tabarés; Anna López-Ferrer; Reinhard Brossmer; Carme de Bolós; Rafael de Llorens
Journal:  Glycoconj J       Date:  2005-03       Impact factor: 2.916

Review 2.  Tumour-associated carbohydrate antigens in breast cancer.

Authors:  Aurélie Cazet; Sylvain Julien; Marie Bobowski; Joy Burchell; Philippe Delannoy
Journal:  Breast Cancer Res       Date:  2010-06-08       Impact factor: 6.466

3.  alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.

Authors:  Marta Pérez-Garay; Beatriz Arteta; Lluís Pagès; Rafael de Llorens; Carme de Bolòs; Fernando Vidal-Vanaclocha; Rosa Peracaula
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

4.  Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool.

Authors:  Petra B dos-Santos; Juliana S Zanetti; Gabriela S Vieira-de-Mello; Moacyr B M Rêgo; Alfredo Ribeiro-Silva A; Eduardo Isidoro Carneiro Beltrão
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 5.  Regulation of ST6GAL1 sialyltransferase expression in cancer cells.

Authors:  Kaitlyn A Dorsett; Michael P Marciel; Jihye Hwang; Katherine E Ankenbauer; Nikita Bhalerao; Susan L Bellis
Journal:  Glycobiology       Date:  2021-06-03       Impact factor: 4.313

6.  Glycosyltransferases as Markers for Early Tumorigenesis.

Authors:  Ulrich Andergassen; Friederike Liesche; Alexandra C Kölbl; Matthias Ilmer; Stefan Hutter; Klaus Friese; Udo Jeschke
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

7.  Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.

Authors:  Tatiana Pochechueva; Francis Jacob; Andre Fedier; Viola Heinzelmann-Schwarz
Journal:  Metabolites       Date:  2012-11-14

Review 8.  ST6GAL1: A key player in cancer.

Authors:  Rebecca Garnham; Emma Scott; Karen E Livermore; Jennifer Munkley
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

9.  Increased Serum E-Selectin Levels Were Associated with Cognitive Decline in Patients with Stroke.

Authors:  Jin Li; Junqiang Bao; Chao Gao; Zibin Wei; Liguo Tan; Ping Liu; Zhiwei Wang; Shujuan Tian
Journal:  Int J Gen Med       Date:  2021-03-02

10.  Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion.

Authors:  Pedro Enrique Guerrero; Laura Miró; Bin S Wong; Anna Massaguer; Neus Martínez-Bosch; Rafael de Llorens; Pilar Navarro; Konstantinos Konstantopoulos; Esther Llop; Rosa Peracaula
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.